Date Title Description PDF
02 Mar 2021 On business and financial situation The Company releases a presentation related to an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States  Download
24 Feb 2021 About corporate governance The Company informs about the agreements adopted by the Board of Directors  Download
27 Nov 2020 On business and financial situation The Company publishes the results of the PRISMA-3 study of the efficacy and safety of Doria® in schizophrenic patients in the journal npj Schizophrenia Download
09 Jul 2020 On business and financial situation ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate Download

Pages

Date Title Description PDF
04 Oct 2022 On business and financial situation The Company informs that it has signed a joint venture agreement with Càrniques Ceirà and Grupo Costa to construct a plant for the production of compounds of high technological value.  Download
03 Oct 2022 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the third quarter of 2022 Download
29 Jul 2022 Other relevant información On 26 July 2022 the public deed relating to the Company’s share capital decrease was registered with the Commercial Registry of Madrid. Download
27 Jul 2022 On business and financial situation The Company releases the press release related to the first half 2022 financial results   Download
27 Jul 2022 On business and financial situation The Company releases the first half 2022 financial results presentation Download

Pages

Date Title Description PDF
21 Dec 2011 Acuerdos estratégicos con terceros (2) Download
21 Dec 2011 Acuerdos estratégicos con terceros Download
08 Nov 2011 Información sobre resultados (2) Download
08 Nov 2011 Información sobre resultados Download
08 Nov 2011 Composición de otros órganos de gestión y control Download

Pages